PRP Therapy in India: The Complete Guide to Platelet-Rich Plasma | ALIV

Platelet-rich plasma (PRP) therapy has become one of the most widely offered procedures in India's private healthcare and wellness market — in orthopaedic clinics, hair clinics, dermatology practices, and sports medicine centres. It is also one of the most inconsistently performed and most inaccurately explained treatments available. The range of clinical quality between a carefully prepared, imaging-guided intra-articular PRP injection for knee OA and a poorly centrifuged "PRP" delivered without any targeting in a beauty salon is enormous — and both are marketed using the same terminology. Understanding what PRP actually is, how it works when done correctly, and what it cannot do helps patients make genuinely informed decisions.

What PRP Actually Is

Platelet-rich plasma is produced by drawing a volume of the patient's own peripheral blood (typically 30–120ml depending on the protocol), centrifuging it to separate the blood components by density, and isolating the platelet-rich buffy coat layer — which contains platelets at concentrations three to five times (or more, depending on the preparation system) above the baseline concentration in whole blood. Platelets are the blood cells responsible for haemostasis (clotting) and early wound healing — they contain alpha granules packed with growth factors: PDGF (Platelet-Derived Growth Factor), TGF-β (Transforming Growth Factor-beta), VEGF (Vascular Endothelial Growth Factor), EGF (Epidermal Growth Factor), IGF-1 (Insulin-Like Growth Factor 1), and FGF (Fibroblast Growth Factor). Concentrating platelets concentrates this growth factor payload, which is the therapeutic component of PRP.

What Clinically Separates Good PRP from Poor PRP

Three variables determine whether a PRP preparation has meaningful therapeutic potential. Platelet concentration: a three-to-five times baseline concentration is the therapeutic threshold supported by the evidence — below this, the growth factor concentration may be insufficient for meaningful biological effect. Not all centrifuge systems achieve this; tube-based "bedside" systems vary widely. Leukocyte content: the white blood cell content of PRP is clinically significant and contested — leukocyte-rich PRP (LR-PRP) may produce more robust growth factor delivery but also more post-injection inflammatory response; leukocyte-poor PRP (LP-PRP) is preferred for intra-articular applications where minimising inflammatory response is a priority. The appropriate preparation depends on the indication. Activation status: PRP can be delivered inactivated (releasing growth factors slowly over hours to days) or activated (using thrombin or calcium chloride to trigger immediate growth factor release). Activation strategy is condition-dependent. A provider who cannot specify platelet concentration, leukocyte content, and activation status of their PRP preparation is not prepared to discuss clinical quality meaningfully. See: how to evaluate any regenerative medicine provider.

Where PRP Has the Strongest Evidence

Tendinopathy: Lateral epicondylitis (tennis elbow), patellar tendinopathy, Achilles tendinopathy, and rotator cuff tendinopathy all have evidence supporting PRP over corticosteroid injection for longer-term outcomes. Multiple randomised controlled trials show PRP producing more durable improvements in pain and function than cortisone at six and twelve months — though often similar or worse acute pain relief in the first six weeks. Knee osteoarthritis: A large and growing body of evidence — including several meta-analyses — supports PRP for mild to moderate knee OA, with pain and function improvements comparable to hyaluronic acid injection at six months and superior at twelve months. Hair restoration: Multiple RCTs support PRP for androgenetic alopecia (male and female pattern hair loss) — the mechanism and evidence are covered in detail in the dedicated article: ALIV PRP and specialty therapy pillar.

What PRP Cannot Do

PRP cannot regenerate fully destroyed cartilage, reverse end-stage osteoarthritis, regrow hair in completely scarred follicles, replace the structural function of a ruptured ligament, or cure chronic conditions. Claims of PRP "regrowing cartilage" or "reversing arthritis" overstate the evidence significantly. PRP modulates the biological environment — reducing inflammation, stimulating repair — rather than replacing lost structure. Every honest PRP provider should make this limitation explicit. ALIV's clinical team always does.

How many PRP sessions are typically needed?

For musculoskeletal applications (OA, tendinopathy), one to three sessions at four to six week intervals is typical — though many patients see meaningful benefit from a single session. For hair restoration, a series of three to four monthly sessions as an initial course is standard, followed by maintenance every three to six months. The appropriate number of sessions depends on the application, the patient's response, and the specific protocol — ALIV's clinical team defines this at the pre-treatment consultation.

Is PRP covered by insurance in India?

PRP is not covered by standard Indian health insurance policies for most applications. As a biologic regenerative procedure rather than a pharmaceutical treatment, it falls outside standard medical coverage. Some comprehensive or corporate health policies may include provisions — patients should check directly with their insurer. ALIV provides complete clinical documentation for insurance submission purposes.

How does ALIV's PRP differ from PRP offered at a beauty salon?

The differences are fundamental: clinical-grade centrifuge systems calibrated for specific platelet yields; physician-supervised preparation with documented platelet concentration; imaging-guided delivery for intra-articular applications; trained medical staff administering under sterile conditions; and a clinical follow-up framework to assess response. A "PRP facial" in a salon environment involves none of these quality controls — the preparation is different, the administration is surface rather than therapeutic, and the clinical framework is absent. PRP as a cosmetic surface treatment and PRP as a therapeutic biological intervention are categorically different procedures sharing only the name.